International Stem Cell Q3 2026 Results: Net Income $21.8M, Up 38107.0% YoY
International Stem Cell Corporation reported a significant net income of $21.5 million for the nine months ended September 30, 2026, primarily driven by a $24.0 million gain from discontinued operations following the sale of a business. The company's cash position strengthened to $20.0 million, while it continued to experience operating losses from its continuing stem cell research and product sales activities.
- Key figure
- Net income $21.8M · +38107.0% YoY